Related Experiment Video
Updated: Apr 29, 2026

04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
2.1K
Cancer cells with irons in the fire
Laura M Bystrom1, Stefano Rivella2
1Department of Pediatrics-Hematology/Oncology, Weill Cornell Medical College, New York, NY 10021, USA.
Free Radical Biology & Medicine
|May 20, 2014
Summary
Iron is vital for cell growth but excess iron can promote cancer. Depleting iron may offer a new cancer treatment strategy by exploiting cancer cells
Area of Science:
- Biochemistry and Molecular Biology
- Cancer Biology and Therapeutics
Background:
- Iron is essential for cellular functions, including growth and proliferation.
- However, iron's pro-oxidative properties link excess iron to DNA damage and cancer development.
- Iron overload disorders are associated with increased cancer risk.
Purpose of the Study:
- To review the dual role of iron in biological systems and its specific impact on cancer.
- To explore the vulnerabilities of iron-dependent cancer cells to iron depletion and oxidative stress.
- To discuss the potential of targeting iron metabolism for cancer prevention and treatment.
Main Methods:
- Literature review of studies on iron metabolism, oxidative stress, and cancer.
- Analysis of the relationship between iron levels and cancer development.
- Examination of the differential sensitivity of cancer cells versus normal cells to iron modulation.
Main Results:
- Excess iron contributes to carcinogenesis through oxidative damage.
- Cancer cells exhibit a heightened dependence on iron, making them more susceptible to iron depletion.
- Combined strategies targeting iron metabolism and oxidative stress show therapeutic promise.
Conclusions:
- Iron metabolism is a critical factor in cancer development and progression.
- Exploiting the iron dependency of cancer cells offers a potential therapeutic avenue.
- Targeting iron dysregulation, alongside oxidative stress, may lead to novel cancer treatments.
Related Concept Videos
Necrosis
5.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
5.2K
The Early Endosome: Endocytosis of Transferrin
4.1K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Adaptive Mechanisms in Cancer Cells
3.8K
3.8K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression
1.5K
1.5K

